Chronic Disease
Our work in Chronic Disease
-
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
Current cancer-screening and reimbursement paradigms should be revised to recognize the value of new technologies available.
Categorized in -
American Life in Realtime: a Benchmark Registry of Health Data for Equitable Precision Health
Applying artificial intelligence and machine learning to person-generated health data allows unprecedented assessment of associations between everyday life and health outcomes.
Categorized in -
Telling Doctors Their Patients Fatally Overdosed Reduces Opioid Prescriptions Up to One Year Later
Those clinicians who received the letter wrote 7% fewer prescriptions than clinicians who hadn’t received the notification.
Categorized in -
Hidden Physician Financial Conflicts of Interest in Dialysis
Nephrologists’ ownership of dialysis facilities doesn’t affect outcomes, but why is it so secret?
Categorized in -
Shame Won’t Solve America’s Obesity Crisis: How Congress Can Help
If saving lives is the objective, then logic, clinical evidence and compassion dictate that Medicare should pay for preventing and treating obesity, starting now.
Categorized in -
New Dialysis Studies Inform Delivery of Care, Ways to Improve Patient Outcomes
Researchers analyzed the effects of clinic ownership and dialysis timing on patient outcomes.
Categorized in -
Rates of Eye Care and Diabetic Eye Disease among Insured Patients with Newly Diagnosed Type 2 Diabetes
The majority of diabetic patients do not receive adequate eye care within the 5 years after initial diabetes diagnosis despite having insurance.
Categorized in -
Schaeffer Center Economic Modeling Contributes to National Academy Report on Diversity in Clinical Trials
Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades.
Categorized in -
The Relationship Between Multimorbidity and Types of Chronic Diseases and Self-Rated Memory
This study explores the impact of multimorbidity and types of chronic diseases on self-rated memory in older adults in the United States.
Categorized in -
Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma
Researchers aimed to quantify the value of reducing chimeric antigen receptor T-cell (CAR-T) treatment wait times on patients with refractory and relapsed aggressive blood cancer who can newly gain access to treatment or access treatment earlier in their disease course.
Categorized in